Trade Mark Journal No.2026/018 1 May 2026
WO0000001912888 (5,42)
Office of origin: United States of America
Date of International Registration:23 February 2026
Date of designation in the UK:
23 February 2026
The mark consists of a navy blue circle containing interlocking wavey lines of royal blue, turquoise, navy blue, and aquamarine all originating from a point on the left of the circle and ending at another point on the right of the circle.
The mark contains the colours navy blue, royal blue, turquoise and aquamarine.
The mark consists of a navy blue circle containing interlocking wavey lines of royal blue, turquoise, navy blue, and aquamarine all originating from a point on the left of the circle and ending at another point on the right of the circle.
International priority date claimed: 29 August 2025
(United States of America)
(99366346)
- Class 5
- Pharmaceutical preparations for the treatment of myeloproliferative neoplasms and other hematologic diseases.
- Class 42
- Pharmaceutical research in the field of hematology and oncology.
Calytrix Bio, Inc.
Representative: Michael R. Graif Brown Rudnick LLP, 7 Times Square,, Fl. 44, New York NY 10036, UNITED STATES OF AMERICA